全球患者血液管理市场：市场规模、份额、成长分析：按类型、按应用分类 - 行业预测

Global Patient Blood Management Market Size, Share, Growth Analysis, By Type(Instruments, Software and Consumables), By Application(Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management) - Industry Forecast 2023-203

出版日期: 2023年10月15日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计2021年全球患者血液管理市场规模将达122亿美元，2022年将达129.7亿美元。预计该市场在预测期（2023-2030年）将以6.3%的年复合成长率成长，到2030年将达到211.4亿美元。

由于慢性病盛行率上升、外科手术数量增加以及对患者血液管理策略益处的认识不断提高等多种因素，全球患者血液管理市场正在显着增长。患者血液管理 (PBM) 涉及一种综合方法来最佳化可能需要输血的患者的护理，旨在改善患者的治疗结果并儘可能减少输血的需要。目的是全球市场的主要驱动因素之一是心血管疾病、癌症和血液疾病等慢性疾病的盛行率不断上升。这些疾病通常需要手术干预，并且可能需要输血。然而，由于输血会带来风险和併发症，医疗保健提供者越来越多地采用患者血液管理策略，以尽量减少输血的使用。这一趋势正在推动对患者血液管理解决方案和服务的需求。对改善手术结果、减少併发症和缩短住院时间的重视正在推动患者血液管理方案的采用，从而导致市场成长。输血涉及各种风险，包括感染疾病、免疫反应和输血相关併发症。

随着血液管理新技术和技术的出现，输血医学领域取得了重大进展。这些进步显着提高了输血的安全性和有效性，并促进了患者血液管理的采用。

患者血液管理实践通常需要偏离既定的输血实践和医疗规范。克服变革阻力、适应医生偏好以及提供适当的培训和教育是广泛接受患者血液管理方法的挑战。

该报告研究了全球患者血液管理市场，并提供了市场概述，包括按类型、应用、地区和参与市场的公司概况分類的趋势。

主要企业简介
- Fresenius SE &Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- B. Braun Melsungen AG
- Bio-Rad Laboratories, Inc.
- LivaNova PLC
- Medtronic PLC
- Abbott Laboratories
- Grifols, SA
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Immucor, Inc.
- BioMerieux SA
- Ortho Clinical Diagnostics
- Fresenius Kabi AG
- Kedrion SpA
- Octapharma AG
- Beckman Coulter, Inc
- Siemens Healthineers AG
- Quidel Corporation

简介目录

Product Code: SQMIG35D2100

Global Patient Blood Management Market size was valued at USD 12.2 billion in 2021 and is poised to grow from USD 12.97 billion in 2022 to USD 21.14 billion by 2030, growing at a CAGR of 6.3% during the forecast period (2023-2030).

The global patient blood management market is experiencing significant growth, driven by various factors such as the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness about the benefits of patient blood management strategies. Patient blood management (PBM) involves a comprehensive approach to optimize the care of patients who might need blood transfusion, aiming to improve patient outcomes and reduce the need for blood transfusions whenever possible. One of the key drivers of the global market is the rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and blood disorders. These conditions often require surgical interventions, which may involve the need for blood transfusions. However, healthcare providers are increasingly adopting patient blood management strategies to minimize the use of blood transfusions, as they are associated with risks and complications. This trend is fueling the demand for patient blood management solutions and services. The emphasis on improving surgical outcomes, reducing complications, and shortening hospital stays is driving the adoption of patient blood management protocols, leading to market growth. Blood transfusions are associated with various risks, including infections, immune reactions, and transfusion-related complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Patient Blood Management Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Patient Blood Management Market Segmental Analysis

Global Patient Blood Management Market is segmented by type, application, and region. Based on type, the market can be segmented into Instruments, Software and Consumables. Based on application, the market is segmented into Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Patient Blood Management Market

Advancements in transfusion medicine

The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

Restraints in the Global Patient Blood Management Market

Challenges in changing transfusion practices

The implementation of patient blood management practices often necessitates a departure from established transfusion methods and medical norms. Overcoming resistance to change, accommodating physician preferences, and providing adequate training and education present challenges to the widespread acceptance of patient blood management approaches.

Market Trends of the Global Patient Blood Management Key

One significant market trend in the global patient blood management market is the increasing focus on personalized and evidence-based approaches to optimize blood transfusion practices. This trend emphasizes the importance of tailoring blood transfusion strategies to individual patients based on their specific needs and clinical conditions, rather than adopting a one-size-fits-all approach. Healthcare providers and organizations are recognizing the potential risks and complications associated with unnecessary blood transfusions, such as transfusion reactions, infections, and increased healthcare costs.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Patient Blood Management Market by Type
- Market Overview
- Instruments
- Software and Consumables
Global Patient Blood Management Market by Application
- Market Overview
- Preoperative Anemia Management
- Acute Blood Loss Management and Chronic Blood Loss Management
Global Patient Blood Management Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Fresenius SE & Co. KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Haemonetics Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Terumo Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LivaNova PLC (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic PLC (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abbott Laboratories (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Grifols, S.A. (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffmann-La Roche Ltd (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Danaher Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Immucor, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioMerieux SA (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ortho Clinical Diagnostics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Fresenius Kabi AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Kedrion S.p.A. (Italy)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Octapharma AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beckman Coulter, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Siemens Healthineers AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Quidel Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments